Core Viewpoint - Xinde New Materials (301349.SZ) reported an increase in institutional and foreign investment holdings in its third-quarter report for 2025, indicating growing confidence from investors in the company's performance and prospects [1][2]. Group 1: Institutional Holdings - As of October 26, 2025, a total of 9 institutional investors disclosed holdings in Xinde New Materials A-shares, with a combined holding of 15.03 million shares, representing 15.03% of the total share capital [1]. - The institutional holding ratio increased by 1.15 percentage points compared to the previous quarter [1]. - Notable institutional investors include Liaoyang Xinde Enterprise Management Consulting Center (Limited Partnership), Goldman Sachs, UBS AG, and CITIC Securities Asset Management (Hong Kong) [1]. Group 2: Public Fund Holdings - In the current period, 53 public funds were disclosed, including Anxin Consumption Medicine Stock A, Anxin New Growth Mixed A, and Southern Junxin Flexible Allocation Mixed A, which were not reported in the previous quarter [1]. Group 3: Foreign Investment - One foreign fund, UBS AG, increased its holdings by 0.15% compared to the previous period [2]. - Three new foreign institutions disclosed their holdings, including Goldman Sachs, CITIC Securities Asset Management (Hong Kong), and Barclays Bank PLC [2].
机构风向标 | 信德新材(301349)2025年三季度已披露持仓机构仅9家